semaglutide alzheimer clinical trial Results from the latest trials show semaglutide, a drug used to treat type 2 diabetes and help with weight loss under the brand names Rybelsus, Ozempic, and Wegovy, does not slow UK Dementia Research Institute responds

Be alert for signs of hypersensitivity reactions like anaphylaxis and angioedema, which have been reported in some cases

Availability and Warnings: Availability: For General Sale (APVMA [Injection] 40293)

Product Facts Supplement Facts Serving Size 8.5 g (1 scoop) Servings Per Container 30 Daily Value not established

doi: 10.1021/acs.jmedchem.5b00726 96 DeaconCFKnudsenLBMadsenKWibergFCJacobsenOHolstJJ

Studies had previously suggested the rate of dementia was lower in people with type 2 diabetes who take drugs such as semaglutide, compared with those given a placebo

No, clinical trials have not shown increased infection susceptibility with semaglutide